View in EDS

Clinical impact of bacterial heteroresistance.

Saved in:
Bibliographic Details
Title: Clinical impact of bacterial heteroresistance.
Authors: Joyce C; Science and Research, Medicines and Healthcare Products Regulatory Agency, South Mimms, Hertfordshire, UK., Anwar S; Science and Research, Medicines and Healthcare Products Regulatory Agency, South Mimms, Hertfordshire, UK., Hind C; Antimicrobial Discovery Development and Diagnostics (AD3) Team, Vaccine Development and Evaluation Centre, UK Health Security Agency, Porton Down, Salisbury, Wiltshire SP4 0JG, UK., Sutton JM; Antimicrobial Discovery Development and Diagnostics (AD3) Team, Vaccine Development and Evaluation Centre, UK Health Security Agency, Porton Down, Salisbury, Wiltshire SP4 0JG, UK.; Institute of Pharmaceutical Science, King's College London, London SE1 1DB, UK., Sergaki C; Science and Research, Medicines and Healthcare Products Regulatory Agency, South Mimms, Hertfordshire, UK.
Source: JAC-antimicrobial resistance [JAC Antimicrob Resist] 2026 May 22; Vol. 8 (3), pp. dlag075. Date of Electronic Publication: 2026 May 22 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101765283 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1823 (Electronic) Linking ISSN: 26321823 NLM ISO Abbreviation: JAC Antimicrob Resist Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2632-1823
DOI:10.1093/jacamr/dlag075